Strategic Blueprint’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,643
| Closed | -$280K | – | 688 |
|
|
2025
Q1 | $280K | Buy |
1,643
+75
| +5% | +$12.8K | 0.02% | 555 |
|
|
2024
Q4 | $261K | Sell |
1,568
-26
| -2% | -$4.32K | 0.02% | 559 |
|
|
2024
Q3 | $274K | Sell |
1,594
-86
| -5% | -$14.8K | 0.02% | 533 |
|
|
2024
Q2 | $259K | Sell |
1,680
-53
| -3% | -$8.16K | 0.02% | 523 |
|
|
2024
Q1 | $266K | Sell |
1,733
-17
| -1% | -$2.61K | 0.02% | 517 |
|
|
2023
Q4 | $277K | Buy |
1,750
+50
| +3% | +$7.9K | 0.02% | 479 |
|
|
2023
Q3 | $249K | Sell |
1,700
-60
| -3% | -$8.78K | 0.02% | 463 |
|
|
2023
Q2 | $270K | Buy |
1,760
+26
| +1% | +$3.98K | 0.03% | 447 |
|
|
2023
Q1 | $269K | Buy |
+1,734
| New | +$269K | 0.03% | 440 |
|
|
2021
Q3 | – | Sell |
-951
| Closed | -$164K | – | 665 |
|
|
2021
Q2 | $164K | Buy |
+951
| New | +$164K | 0.03% | 388 |
|